Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations-Reference-Cited by-同舟云学术

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

Published:2022-01-11 Issue:6 Volume:40 Page:601-609
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Husereau Don^ORCID,Drummond Michael,Augustovski Federico,de Bekker-Grob Esther,Briggs Andrew H.,Carswell Chris,Caulley Lisa,Chaiyakunapruk Nathorn,Greenberg Dan,Loder Elizabeth,Mauskopf Josephine,Mullins C. Daniel,Petrou Stavros,Pwu Raoh-Fang,Staniszewska Sophie

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40273-021-01112-8.pdf

Reference50 articles.

1. Pitt C, Goodman C, Hanson K. Economic evaluation in global perspective: a bibliometric analysis of the recent literature. Health Econ. 2016;25(Suppl 1):9–28. https://doi.org/10.1002/hec.3305.

2. Neumann PJ, Thorat T, Shi J, Saret CJ, Cohen JT. The changing face of the cost-utility literature, 1990–2012. Value Health. 2015;18:271–7. https://doi.org/10.1016/j.jval.2014.12.002.

3. Panzer AD, Emerson JG, D’Cruz B, et al. Growth and capacity for cost-effectiveness analysis in Africa. Health Econ. 2020;29:945–54. https://doi.org/10.1002/hec.4029.

4. Husereau D, Drummond M, Petrou S, et al. ISPOR Health economic evaluation publication guidelines-CHEERS good reporting practices task force. consolidated health economic evaluation reporting standards (CHEERS)—explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health. 2013;16:231–50. https://doi.org/10.1016/j.jval.2013.02.002.

5. Caulley L, Catalá-López F, Whelan J, et al. Reporting guidelines of health research studies are frequently used inappropriately. J Clin Epidemiol. 2020;122:87–94. https://doi.org/10.1016/j.jclinepi.2020.03.006.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of adding a smartphone app (BlueIce) to the mental health care of adolescents who repeatedly self-harm;Psychiatry Research;2024-09

2. Drug Pricing Stewardship from Mark Cuban’s Cost Plus Generic Drug Program;PharmacoEconomics;2024-08-21

3. Health Utility Value of Overactive Bladder in Japanese Older Adults;2024-08-02

4. Systematic Review of Economic Evaluations of Systemic Treatments for Advanced and Metastatic Gastric Cancer;PharmacoEconomics;2024-07-26

5. First-line treatments for extensive-stage small-cell lung cancer with immune checkpoint inhibitors plus chemotherapy: a China-based cost-effectiveness analysis;Frontiers in Immunology;2024-07-05